← Back to Search

ESOGER for Aging (ESOGER-PC Trial)

N/A
Waitlist Available
Led By Nadia Sourial, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
65 years old and older
Patient of the participating primary care clinic with upcoming virtual or in-person primary care visit
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the eq-5d will be measured at study entry (time 0) and at study follow-up (3 months) for both the intervention and control group.
Awards & highlights

ESOGER-PC Trial Summary

This trial is testing a telehealth tool to help family doctors better care for older patients living at home. The tool will be used to evaluate patients' health and social needs, and to see if it helps improve patients' autonomy, quality of life and health service use.

ESOGER-PC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ESOGER-PC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the eq-5d will be measured at study entry (time 0) and at study follow-up (3 months) for both the intervention and control group.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the eq-5d will be measured at study entry (time 0) and at study follow-up (3 months) for both the intervention and control group. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline quality of life score at 3 months

ESOGER-PC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Patients 65 years old and older will receive a pre-consultation screening questionnaire by phone prior to their virtual or in-person visit. A summary report based on the results of the questionnaire will be placed in the patient electronic chart for use by the clinician at the time of visit.
Group II: Control GroupActive Control1 Intervention
Usual care in the primary care clinic

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
365 Previous Clinical Trials
128,857 Total Patients Enrolled
Nadia Sourial, PhDPrincipal InvestigatorUniversité de Montréal

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~136 spots leftby Mar 2025